MedPath

PT. DAEWOONG INFION

🇮🇩Indonesia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients

Completed
Conditions
Chronic Kidney Disease (CKD)
First Posted Date
2022-06-16
Last Posted Date
2022-07-22
Lead Sponsor
PT. Daewoong Infion
Target Recruit Count
200
Registration Number
NCT05422755
Locations
🇮🇩

Gatot Soebroto Army Hospital, Jakarta, DKI Jakarta, Indonesia

The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®

Not Applicable
Completed
Conditions
Chronic Kidney Disease (CKD)
First Posted Date
2022-05-13
Last Posted Date
2022-07-14
Lead Sponsor
PT. Daewoong Infion
Target Recruit Count
82
Registration Number
NCT05373303
Locations
🇮🇩

Gatot Soebroto Army Hospital, Jakarta, Indonesia

Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)

Not Applicable
Completed
Conditions
Skin Graft Scar
Split-Thickness Skin Graft (STSG)
Interventions
First Posted Date
2022-04-19
Last Posted Date
2022-07-22
Lead Sponsor
PT. Daewoong Infion
Target Recruit Count
10
Registration Number
NCT05335720
Locations
🇮🇩

RSPAD Gatot Soebroto, Central Jakarta, DKI Jakarta, Indonesia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.